CYAD.BR Celyad Oncology EURONEXT +34.93% intraday 16 Feb 2026: high-volume alert

CYAD.BR stock surged +34.93% intraday to €0.367 on 16 Feb 2026 on a volume spike of 128,672 shares, roughly 11.23x the average. That jump is the defining intraday move for Celyad Oncology SA (CYAD.BR) on EURONEXT and puts the micro-cap biotech back on trader screens. We look at what drove the volume, how financials and technicals line up, and what the Meyka AI grade and model imply for next moves.